Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Long Term Debt 2011-2025 | MKKGY

Merck long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Merck long term debt for the quarter ending June 30, 2025 was $7.151B, a 15.11% decline year-over-year.
  • Merck long term debt for 2024 was $7.571B, a 24.28% decline from 2023.
  • Merck long term debt for 2023 was $9.999B, a 3.16% increase from 2022.
  • Merck long term debt for 2022 was $9.693B, a 0.93% decline from 2021.
Merck Annual Long Term Debt
(Millions of US $)
2024 $7,571
2023 $9,999
2022 $9,693
2021 $9,784
2020 $11,177
2019 $9,681
2018 $7,890
2017 $9,080
2016 $9,748
2015 $10,671
2014 $4,734
2013 $4,327
2012 $4,324
2011
2010
Merck Quarterly Long Term Debt
(Millions of US $)
2025-06-30 $7,151
2025-03-31 $7,337
2024-12-31 $7,571
2024-09-30 $8,669
2024-06-30 $8,424
2024-03-31 $8,493
2023-12-31 $9,999
2023-09-30 $10,383
2023-06-30 $10,353
2023-03-31 $9,831
2022-12-31 $9,693
2022-09-30 $9,333
2022-06-30 $9,988
2022-03-31 $9,299
2021-12-31 $9,784
2021-09-30 $9,664
2021-06-30 $10,508
2021-03-31 $10,852
2020-12-31 $11,177
2020-09-30 $69
2020-06-30 $11,100
2020-03-31 $11,183
2019-12-31 $9,681
2019-09-30 $9,579
2019-06-30 $7,303
2019-03-31 $5,732
2018-12-31 $7,890
2018-09-30 $8,249
2018-06-30 $9,648
2018-03-31 $9,755
2017-12-31 $9,080
2017-09-30 $9,481
2017-06-30 $8,966
2017-03-31 $8,911
2016-12-31 $9,748
2016-09-30 $9,581
2016-06-30 $10,494
2016-03-31 $10,217
2015-12-31 $10,671
2015-09-30 $10,190
2015-06-30 $7,609
2015-03-31 $8,159
2014-12-31 $4,734
2014-09-30 $2,868
2014-06-30 $2,657
2014-03-31 $2,628
2013-12-31 $4,327
2013-09-30 $4,338
2013-06-30 $4,314
2013-03-31 $4,445
2012-12-31 $4,324
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.217B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.40
Zoetis (ZTS) United States $53.394B 19.11
Takeda Pharmaceutical (TAK) Japan $45.311B 9.25
Daiichi Sankyo, - (DSNKY) Japan $41.164B 20.50
BeOne Medicines - (ONC) Switzerland $40.396B 214.16
Sandoz Group AG (SDZNY) Switzerland $30.312B 0.00
United Therapeutics (UTHR) United States $19.905B 17.52
Shionogi (SGIOY) Japan $14.768B 13.56
Neurocrine Biosciences (NBIX) United States $14.374B 34.49
Summit Therapeutics (SMMT) United States $14.081B 0.00
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.695B 0.00
Ionis Pharmaceuticals (IONS) United States $11.312B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.353B 0.00
Corcept Therapeutics (CORT) United States $7.968B 86.08
Stevanato Group S.p.A (STVN) Italy $6.862B 38.41
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.130B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.931B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.621B 17.19
Centessa Pharmaceuticals (CNTA) United Kingdom $3.478B 0.00
Hypermarcas (HYPMY) Brazil $3.028B 20.78
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.829B 9.03
Dyne Therapeutics (DYN) United States $2.689B 0.00
Soleno Therapeutics (SLNO) United States $2.543B 0.00
Ocular Therapeutix (OCUL) United States $2.384B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.007B 23.78
Guardian Pharmacy Services (GRDN) United States $1.926B 37.10
Avadel Pharmaceuticals (AVDL) Ireland $1.879B 0.00
Collegium Pharmaceutical (COLL) United States $1.466B 7.26
BioCryst Pharmaceuticals (BCRX) United States $1.453B 86.25
Ardelyx (ARDX) United States $1.417B 0.00
Harrow (HROW) United States $1.403B 86.11
Amylyx Pharmaceuticals (AMLX) United States $1.364B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Enliven Therapeutics (ELVN) United States $1.203B 0.00
Evotec AG (EVO) Germany $1.126B 0.00
Relay Therapeutics (RLAY) United States $1.118B 0.00
Nektar Therapeutics (NKTR) United States $1.097B 0.00
Oruka Therapeutics (ORKA) United States $1.096B 0.00
Xencor (XNCR) United States $0.999B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Theravance Biopharma (TBPH) United States $0.910B 38.19
Savara (SVRA) United States $0.867B 0.00
ARS Pharmaceuticals (SPRY) United States $0.831B 0.00
Organogenesis (ORGO) United States $0.788B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.724B 6.46
Elite Pharmaceuticals (ELTP) United States $0.719B 0.00
Esperion Therapeutics (ESPR) United States $0.708B 0.00
ProKidney (PROK) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.662B 0.00
Lexeo Therapeutics (LXEO) United States $0.656B 0.00
Aquestive Therapeutics (AQST) United States $0.647B 0.00
Bioventus (BVS) United States $0.627B 12.83
4D Molecular Therapeutics (FDMT) United States $0.587B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.547B 12.96
Zevra Therapeutics (ZVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.435B 5.96
Altimmune (ALT) United States $0.424B 0.00
Lyell Immunopharma (LYEL) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 21.60
Galectin Therapeutics (GALT) United States $0.357B 0.00
USANA Health Sciences (USNA) United States $0.354B 9.88
Aldeyra Therapeutics (ALDX) United States $0.302B 0.00
Pyxis Oncology (PYXS) United States $0.279B 0.00
Larimar Therapeutics (LRMR) United States $0.272B 0.00
Avalo Therapeutics (AVTX) United States $0.267B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
OmniAb (OABI) United States $0.219B 0.00
AleAnna (ANNA) United States $0.217B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Protara Therapeutics (TARA) United States $0.203B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.151B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.142B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Relmada Therapeutics (RLMD) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.124B 0.00
Inhibikase Therapeutics (IKT) United States $0.119B 0.00
Unicycive Therapeutics (UNCY) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Gain Therapeutics (GANX) United States $0.108B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Champions Oncology (CSBR) United States $0.095B 34.50
Prelude Therapeutics (PRLD) United States $0.095B 0.00
Karyopharm Therapeutics (KPTI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.088B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.072B 0.00
Plus Therapeutics (PSTV) United States $0.072B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Lite Strategy (LITS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.061B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Wellgistics Health (WGRX) United States $0.049B 0.00
Talphera (TLPH) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 26.12
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Mangoceuticals (MGRX) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.22
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00